These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33092993)

  • 1. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block.
    Wilson BL; Israel AK; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma.
    Velez Torres JM; Alkathery T; Tjendra Y; Zuo Y; Kerr DA; Gomez-Fernandez C
    Cancer Cytopathol; 2023 Mar; 131(3):165-170. PubMed ID: 36350307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong SOX10 expression in human papillomavirus-related multiphenotypic sinonasal carcinoma: report of 6 new cases validated by high-risk human papillomavirus mRNA in situ hybridization test.
    Hsieh MS; Lee YH; Jin YT; Huang WC
    Hum Pathol; 2018 Dec; 82():264-272. PubMed ID: 30071233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of high-risk human papillomavirus in situ hybridization in cytology cell block material from cystic head and neck lesions.
    Han LM; Saunders TA; Calkins SM
    Cancer Cytopathol; 2022 Feb; 130(2):154-160. PubMed ID: 34758205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
    Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
    Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
    Hou Y; Chaudhary S; Shen R; Li Z
    Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Berdugo J; Rooper LM; Chiosea SI
    Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Risk Human Papillomavirus E6/E7 mRNA Is Rarely Detected in Nonanogenital Cutaneous Squamous Cell Carcinoma: An RNA In Situ Hybridization-Based Tissue Microarray Study.
    Fujimoto M; Matsuzaki I; Takahashi Y; Iwahashi Y; Warigaya K; Kojima F; Jinnin M; Murata SI
    Am J Dermatopathol; 2019 Mar; 41(3):205-210. PubMed ID: 30640756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.
    Randén-Brady R; Carpén T; Jouhi L; Syrjänen S; Haglund C; Tarkkanen J; Remes S; Mäkitie A; Mattila PS; Silén S; Hagström J
    Hum Pathol; 2019 Aug; 90():97-105. PubMed ID: 31121191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic evaluation of p16 staining in head and neck squamous cell carcinoma in CytoLyt versus formalin-fixed material.
    Buonocore DJ; Fowle E; Lin O; Xu B; Katabi N; Cohen JM
    Cancer Cytopathol; 2019 Dec; 127(12):750-756. PubMed ID: 31600033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
    Shi W; Kato H; Perez-Ordonez B; Pintilie M; Huang S; Hui A; O'Sullivan B; Waldron J; Cummings B; Kim J; Ringash J; Dawson LA; Gullane P; Siu L; Gillison M; Liu FF
    J Clin Oncol; 2009 Dec; 27(36):6213-21. PubMed ID: 19884544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
    Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
    Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.